|
End-of-day quote
Amman S.E.
2026-08-23
|
5-day change | 1st Jan Change | ||
| 1.840 JOD | 0.00% |
|
-7.07% | +15.00% |
| 07-21 | Philadelphia Pharmaceuticals Company Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-27 | Philadelphia Pharmaceuticals Q1 profit 255,632 dinars | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | 0.00% | -7.07% | -8.00% | +6.98% | +15.00% | +26.03% | +29.58% | +33.33% | -39.67% | 19.48M | |
| -0.08% | -1.43% | -2.64% | +3.13% | +10.62% | +15.87% | +69.30% | +150.53% | +149.54% | 47.71B | |
| +0.08% | +1.58% | +9.41% | +5.90% | +37.55% | +52.18% | +123.09% | +157.38% | +162.87% | 40.3B | |
| -0.40% | -1.23% | +2.81% | +2.36% | -5.23% | -10.08% | +16.38% | +59.43% | +157.75% | 12.09B | |
| +1.11% | -1.34% | +0.56% | +7.80% | +22.49% | +13.27% | +73.55% | +104.72% | +200.95% | 11.68B | |
| +0.19% | +0.58% | -0.38% | +0.58% | +28.08% | +30.98% | +158.71% | +135.29% | +339.19% | 9.19B | |
| -0.39% | -0.92% | +10.56% | +7.33% | +30.56% | +20.49% | +38.72% | +41.62% | +130.00% | 7.57B | |
| -0.29% | +1.35% | +0.25% | +0.12% | +12.36% | +46.56% | -11.75% | -6.55% | -15.01% | 7.24B | |
| -0.64% | -0.02% | +5.12% | +2.60% | +13.89% | +19.65% | +205.65% | +339.29% | +173.11% | 6.84B | |
| -5.36% | -6.36% | -6.52% | -7.55% | -34.05% | -38.04% | +22.49% | +30.25% | +13.31% | 5.42B | |
| -0.51% | -0.90% | +5.81% | +17.13% | +31.45% | +37.95% | +106.02% | +144.20% | +175.91% | 4.75B | |
| +2.78% | +2.75% | -1.28% | +8.96% | +26.41% | +41.88% | -21.19% | -20.94% | -59.25% | 4.09B | |
| -3.73% | -5.98% | -8.64% | +13.24% | -2.84% | -21.42% | +77.56% | +46.11% | - | 3.96B | |
| +3.04% | -2.40% | +1.98% | +19.73% | +30.43% | +27.50% | +713.59% | +340.83% | +138.15% | 3.2B | |
| 0.00% | -1.08% | +9.21% | +4.17% | -2.96% | -5.04% | +50.77% | +215.73% | +743.04% | 2.93B | |
| -7.71% | -10.74% | +1.57% | -54.65% | -27.44% | -3.76% | +198.06% | +184.97% | +1,621.43% | 2.85B | |
| -0.73% | +3.97% | +15.82% | +0.47% | -16.18% | -26.50% | +55.01% | +93.76% | +14.10% | 2.83B | |
| -1.39% | -2.37% | -8.16% | -10.22% | -5.29% | +5.84% | +57.98% | +10.41% | +67.80% | 2.63B | |
| +1.35% | +0.85% | +0.21% | -6.98% | +0.28% | -9.51% | +25.40% | - | - | 2.62B | |
| -4.15% | -5.09% | +3.43% | -10.50% | +9.54% | -44.61% | +96.00% | +46.92% | - | 2.45B | |
| Average | -0.84% | -1.48% | +1.56% | +0.53% | +8.73% | +8.96% | +104.24% | +110.91% | +233.72% | 9.02B | |
| Weighted average by Cap. | -0.33% | -0.63% | +2.38% | +3.14% | +16.25% | +20.71% | +93.43% | +128.85% | +182.40% |
- Stock Market
- Stocks
- PHIL Stock
- Sector Philadelphia Pharmaceuticals Company
Select your edition
All financial news and data tailored to specific country editions
